{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:03:14Z","timestamp":1790352194152,"version":"4.1.0"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Illicit drug use in the United States continues to rise, alongside an increasing number of severe infections associated with drug use. Surveillance studies report that 28%\u201334% of candidemia cases are linked to intravenous drug use, with Candida albicans being the most commonly isolated species, followed by Candida parapsilosis and Candida glabrata. Marijuana use is associated with lung infections caused by Aspergillus and the Mucorales, showing a 3.5-fold increased risk of mold infections and a 2.2-fold increased risk for other fungal infections. Intravenous drug use also presents a recognized risk factor for Aspergillus and Mucorales infections. Additionally, substances like cannabis, methamphetamines, and opioids share metabolic pathways with triazoles, a class of antifungal, and terbinafine through the CYP enzyme system. These antifungal drugs strongly inhibit CYP3A4 and CYP2D6, leading to potential drug interactions, adverse effects, overdose risks, and even death.<\/jats:p>","DOI":"10.1093\/ofid\/ofaf107","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T13:56:17Z","timestamp":1740405377000},"source":"Crossref","is-referenced-by-count":3,"title":["Fungal Infections in People Who Use Drugs"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0688-1033","authenticated-orcid":false,"given":"Jose","family":"Portugal Gonzales","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, The University of Texas Health Science Center at Houston , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-7589","authenticated-orcid":false,"given":"Luis","family":"Ostrosky-Zeichner","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, The University of Texas Health Science Center at Houston , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"2025052712075293100_ofaf107-B1"},{"key":"2025052712075293100_ofaf107-B2","year":"2022"},{"key":"2025052712075293100_ofaf107-B3","year":"2023"},{"key":"2025052712075293100_ofaf107-B4","year":"2024"},{"key":"2025052712075293100_ofaf107-B5","doi-asserted-by":"crossref","first-page":"1274719","DOI":"10.3389\/fpubh.2023.1274719","article-title":"Opioid use disorder: current trends and potential treatments","volume":"11","author":"Lee","year":"2024","journal-title":"Front Public Health"},{"key":"2025052712075293100_ofaf107-B6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025052712075293100_ofaf107-B7","year":"2022"},{"key":"2025052712075293100_ofaf107-B8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"5","author":"Degenhardt","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2025052712075293100_ofaf107-B9","year":"2018"},{"key":"2025052712075293100_ofaf107-B10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3201\/eid2404.171807","article-title":"Reemergence of intravenous drug use as risk factor for candidemia, Massachusetts, USA","volume":"24","author":"Poowanawittayakom","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2025052712075293100_ofaf107-B11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections from 2002 to 2012","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"Supplement_5","key":"2025052712075293100_ofaf107-B12","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiaa149","article-title":"National public health burden estimates of endocarditis and skin and soft-tissue infections related to injection drug use: a review","volume":"222","author":"See","year":"2020","journal-title":"J Infect Dis"},{"key":"2025052712075293100_ofaf107-B13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2015.10.004","article-title":"The global burden of fungal diseases","volume":"30","author":"Vallabhaneni","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2025052712075293100_ofaf107-B15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/antibiotics11060718","article-title":"Diagnosis and treatment of invasive candidiasis","volume":"11","author":"Barantsevich","year":"2022","journal-title":"Antibiotics"},{"key":"2025052712075293100_ofaf107-B16","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care\u2013associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"key":"2025052712075293100_ofaf107-B17","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1093\/cid\/ciaa193","article-title":"Burden of Candidemia in the United States, 2017","volume":"71","author":"Tsay","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B18","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011","volume":"50","author":"Lockhart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2025052712075293100_ofaf107-B19","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1086\/323759","article-title":"Revisiting the source of candidemia: skin or gut?","volume":"33","author":"Nucci","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B20","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"2025052712075293100_ofaf107-B21","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cid\/ciz1061","article-title":"The changing epidemiology of candidemia in the United States: injection drug use as an increasingly common risk factor\u2014active surveillance in selected sites, United States, 2014\u20132017","volume":"71","author":"Zhang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6808a1","article-title":"Population-based active surveillance for culture-confirmed candidemia\u2014four sites, United States, 2012\u20132016","volume":"68","author":"Toda","year":"2019","journal-title":"MMWR Surveill Summ"},{"issue":"Supplement_5","key":"2025052712075293100_ofaf107-B23","doi-asserted-by":"crossref","first-page":"S442","DOI":"10.1093\/infdis\/jiaa024","article-title":"Injection drug use-associated candidemia: incidence, clinical features, and outcomes, east Tennessee, 2014\u20132018","volume":"222","author":"Rossow","year":"2020","journal-title":"J Infect Dis"},{"key":"2025052712075293100_ofaf107-B24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.15585\/mmwr.mm6812a3","article-title":"Candida bloodstream infections among persons who inject drugs\u2014Denver Metropolitan area, Colorado, 2017\u20132018","volume":"68","author":"Barter","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025052712075293100_ofaf107-B25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/CCM.0000000000002867","article-title":"Initial antifungal strategy reduces mortality in critically ill patients with candidemia: a propensity score\u2013adjusted analysis of a multicenter study","volume":"46","author":"Garnacho-Montero","year":"2018","journal-title":"Crit Care Med"},{"key":"2025052712075293100_ofaf107-B26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B27","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s00417-020-04974-4","article-title":"Antimicrobial guide to posterior segment infections","volume":"259","author":"Patel","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2025052712075293100_ofaf107-B28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diagmicrobio.2015.04.008","article-title":"Isavuconazole, micafungin, and 8 comparator antifungal agents\u2019 susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values","volume":"82","author":"Pfaller","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 2","key":"2025052712075293100_ofaf107-B31","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1017\/ash.2023.255","article-title":"Fluconazole resistance in non-albicans Candida species in the United States, 2012\u20132021","volume":"3","author":"Jenkins","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2025052712075293100_ofaf107-B32"},{"key":"2025052712075293100_ofaf107-B33","doi-asserted-by":"crossref","first-page":"e2484","DOI":"10.1093\/cid\/ciaa1126","article-title":"Against medical advice discharges in injection and non-injection drug use-associated infective endocarditis: a nationwide cohort study","volume":"73","author":"Kimmel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B34"},{"key":"2025052712075293100_ofaf107-B35","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025052712075293100_ofaf107-B36","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1086\/323564","article-title":"Endocarditis caused by Aspergillus species in injection drug users","volume":"33","author":"Petrosillo","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B37"},{"key":"2025052712075293100_ofaf107-B38","doi-asserted-by":"crossref","first-page":"e2011005","DOI":"10.4084\/mjhid.2011.005","article-title":"Too many mouldy joints\u2014marijuana and chronic pulmonary aspergillosis","volume":"3","author":"Gargani","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2025052712075293100_ofaf107-B39","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1001\/jama.284.22.2869","article-title":"Fungal contamination of tobacco and marijuana","volume":"284","author":"Verweij","year":"2000","journal-title":"JAMA"},{"key":"2025052712075293100_ofaf107-B40","first-page":"545","volume-title":"Aspergillosis: from diagnosis to prevention","author":"Trullas","year":"2010"},{"key":"2025052712075293100_ofaf107-B41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3201\/eid2606.191570","article-title":"Cannabis use and fungal infections in a commercially insured population, United States, 2016","volume":"26","author":"Benedict","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2025052712075293100_ofaf107-B42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1378\/chest.112.2.319","article-title":"Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and\/or tobacco","volume":"112","author":"Fligiel","year":"1997","journal-title":"Chest"},{"key":"2025052712075293100_ofaf107-B43","first-page":"209","article-title":"Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers","volume":"135","author":"Tashkin","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2025052712075293100_ofaf107-B44","doi-asserted-by":"crossref","first-page":"e13456","DOI":"10.1111\/ctr.13456","article-title":"Marijuana use in transplantation: a call for clarity","volume":"33","author":"Levi","year":"2019","journal-title":"Clin Transplant"},{"key":"2025052712075293100_ofaf107-B45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00520-014-2429-3","article-title":"Inhaled medicinal cannabis and the immunocompromised patient","volume":"23","author":"Ruchlemer","year":"2015","journal-title":"Support Care Cancer"},{"key":"2025052712075293100_ofaf107-B46","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1016\/j.ijid.2011.08.005","article-title":"Prognosis of acute invasive fungal rhinosinusitis related to underlying disease","volume":"15","author":"Valera","year":"2011","journal-title":"Int J Infect Dis"},{"key":"2025052712075293100_ofaf107-B47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s43163-023-00551-8","article-title":"Invasive fungal rhinosinusitis, clinical manifestations, and prognostic values: as case series audit","volume":"39","author":"Ya\u011fmur","year":"2023","journal-title":"Egypt J Otolaryngol"},{"key":"2025052712075293100_ofaf107-B48","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/313756","article-title":"Practice guidelines for diseases caused by Aspergillus","volume":"30","author":"Kan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B49","doi-asserted-by":"crossref","first-page":"e01327","DOI":"10.1016\/j.idcr.2021.e01327","article-title":"Invasive Aspergillus flavus sinusitis in an immunocompetent patient using intranasal cocaine","volume":"26","author":"Bougioukas","year":"2021","journal-title":"IDCases"},{"key":"2025052712075293100_ofaf107-B50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/000348948409300313","article-title":"Aspergillosis of the paranasal sinuses: X-ray diagnosis, histopathology, and clinical aspects","volume":"93","author":"Stammberger","year":"1984","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2025052712075293100_ofaf107-B51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4103\/0973-029X.102522","article-title":"Chronic invasive aspergillosis of paranasal sinuses: a case report with review of literature","volume":"16","author":"Tamgadge","year":"2012","journal-title":"J Oral Maxillofac Pathol"},{"key":"2025052712075293100_ofaf107-B52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF03008022","article-title":"Destructive aspergillosis","volume":"57","author":"Singhal","year":"2005","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"2025052712075293100_ofaf107-B53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1010-5182(05)80601-8","article-title":"Sinus aspergillosis","volume":"18","author":"De Foer","year":"1990","journal-title":"J Cranio-Maxillofac Surg"},{"key":"2025052712075293100_ofaf107-B54","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(83)91318-1","article-title":"Solitary aspergillosis of maxillary sinus, a complication of dental treatment","volume":"322","author":"Beck-Mannagetta","year":"1983","journal-title":"Lancet"},{"key":"2025052712075293100_ofaf107-B55","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1590\/0037-8682-0086-2014","article-title":"Invasive aspergillosis in a user of inhaled cocaine: rhinosinusitis with bone and cartilage destruction","volume":"47","author":"Azulay-Abulafia","year":"2014","journal-title":"Rev Soc Bras Med Trop"},{"key":"2025052712075293100_ofaf107-B56","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/lary.25429","article-title":"Chronic invasive fungal sinusitis associated with intranasal drug use","volume":"125","author":"Pekala","year":"2015","journal-title":"Laryngoscope"},{"issue":"Supplement_1","key":"2025052712075293100_ofaf107-B57","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1080\/13693780802247702","article-title":"Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus","volume":"47","author":"Pasqualotto","year":"2009","journal-title":"Med Mycol"},{"issue":"s2","key":"2025052712075293100_ofaf107-B58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1439-0507.1997.tb00559.x","article-title":"Clinical presentation of invasive aspergillosis","volume":"40","author":"Schwartz","year":"1997","journal-title":"Mycoses"},{"key":"2025052712075293100_ofaf107-B59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/000348949110000515","article-title":"Sinus aspergillosis and allergic fungal sinusitis","volume":"100","author":"Hartwick","year":"1991","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2025052712075293100_ofaf107-B60","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B61","first-page":"470","article-title":"Aspergillus endophthalmitis in an intravenous drug user","volume":"15","author":"Wilmarth","year":"1983","journal-title":"Ann Ophthalmol"},{"key":"2025052712075293100_ofaf107-B62","doi-asserted-by":"crossref","first-page":"ofaa552","DOI":"10.1093\/ofid\/ofaa552","article-title":"Isolated cerebral mucormycosis in immunocompetent adults who inject drugs: case reports and systematic review of the literature","volume":"7","author":"Meyerowitz","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025052712075293100_ofaf107-B63","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B64","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 5","key":"2025052712075293100_ofaf107-B65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1469-0691.2009.02979.x","article-title":"Cutaneous zygomycosis","volume":"15","author":"Skiada","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2025052712075293100_ofaf107-B66","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11739-010-0375-8","article-title":"Necrotic arm lesions in an intravenous drug user","volume":"5","author":"Adalja","year":"2010","journal-title":"Intern Emerg Med"},{"key":"2025052712075293100_ofaf107-B67","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/abd1806-4841.20176614","article-title":"Cutaneous mucormycosis","volume":"92","author":"Castrej\u00f3n-P\u00e9rez","year":"2017","journal-title":"An Bras Dermatol"},{"key":"2025052712075293100_ofaf107-B68","doi-asserted-by":"crossref","first-page":"100607","DOI":"10.1016\/j.mmcr.2023.100607","article-title":"Cutaneous mucormycosis in the immunocompromised host: an important cause of persistent post traumatic skin lesions","volume":"42","author":"Beliavsky","year":"2023","journal-title":"Med Mycol Case Rep"},{"key":"2025052712075293100_ofaf107-B69","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(89)90242-8","article-title":"Zygomycosis of the basal ganglia in intravenous drug users","volume":"86","author":"Stave","year":"1989","journal-title":"Am J Med"},{"key":"2025052712075293100_ofaf107-B70","doi-asserted-by":"crossref","first-page":"811.e1","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2025052712075293100_ofaf107-B71","first-page":"176","article-title":"Pulmonary mucormycosis associated with medical marijuana use","volume":"26","author":"Stone","year":"2019","journal-title":"Respir Med Case Rep"},{"key":"2025052712075293100_ofaf107-B72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cmi.2016.12.001","article-title":"A microbiome assessment of medical marijuana","volume":"23","author":"Thompson","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2025052712075293100_ofaf107-B73","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.159.12.1301","article-title":"Pulmonary mucormycosis: the last 30 years","volume":"159","author":"Lee","year":"1999","journal-title":"Arch Intern Med"},{"key":"2025052712075293100_ofaf107-B74","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-198603000-00004","article-title":"Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases","volume":"65","author":"Parfrey","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"2025052712075293100_ofaf107-B75","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0090-4295(98)00287-8","article-title":"Primary renal mucormycosis","volume":"52","author":"Lussier","year":"1998","journal-title":"Urology"},{"key":"2025052712075293100_ofaf107-B76","first-page":"e29593","article-title":"A fatal case of isolated renal mucormycosis in an immunocompetent male","volume":"14","author":"Healey","year":"2022","journal-title":"Cureus"},{"key":"2025052712075293100_ofaf107-B77","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2214\/ajr.180.5.1801278","article-title":"Renal mucormycosis in an AIDS patient: imaging features and pathologic correlation","volume":"180","author":"Keogh","year":"2003","journal-title":"Am J Roentgenol"},{"key":"2025052712075293100_ofaf107-B78","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0272-6386(12)70141-5","article-title":"Renal mucormycosis: computerized tomographic findings and their diagnostic significance","volume":"22","author":"Chugh","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"2025052712075293100_ofaf107-B79","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S1473-3099(23)00731-4","article-title":"Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM","volume":"24","author":"Chang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025052712075293100_ofaf107-B80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mmcr.2016.12.003","article-title":"Cases of disseminated cryptococcosis in intravenous drug abusers without HIV infection: a new risk factor?","volume":"14","author":"Shorman","year":"2016","journal-title":"Med Mycol Case Rep"},{"key":"2025052712075293100_ofaf107-B81","doi-asserted-by":"crossref","first-page":"bcr2017221435","DOI":"10.1136\/bcr-2017-221435","article-title":"Cryptococcal meningitis in a daily cannabis smoker without evidence of immunodeficiency","volume":"2018","author":"Bryan B Shapiro","year":"2018","journal-title":"BMJ Case Rep"},{"key":"2025052712075293100_ofaf107-B82","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.3389\/fimmu.2019.02914","article-title":"Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies","volume":"10","author":"Franchi","year":"2019","journal-title":"Front Immunol"},{"key":"2025052712075293100_ofaf107-B83","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system\u2014friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Br J Pharmacol"},{"key":"2025052712075293100_ofaf107-B84","doi-asserted-by":"crossref","first-page":"e00091","DOI":"10.1128\/iai.00091-22","article-title":"Methamphetamine enhances Cryptococcus neoformans melanization, antifungal resistance, and pathogenesis in a murine model of drug administration and systemic infection","volume":"90","author":"Erives","year":"2022","journal-title":"Infect Immun"},{"key":"2025052712075293100_ofaf107-B85","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/infdis\/jit117","article-title":"Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic Cryptococcus neoformans","volume":"208","author":"Eugenin","year":"2013","journal-title":"J Infect Dis"},{"key":"2025052712075293100_ofaf107-B86","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mmcr.2022.05.002","article-title":"Another case of cryptococcal meningitis in a person without HIV who injects drugs: a possible risk factor in need of further investigation","volume":"36","author":"McCrary","year":"2022","journal-title":"Med Mycol Case Rep"},{"key":"2025052712075293100_ofaf107-B87","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12879-020-05108-1","article-title":"Cryptococcus meningitis mimicking cerebral septic emboli, a case report series demonstrating injection drug use as a risk factor for development of disseminated disease","volume":"20","author":"Polk","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2025052712075293100_ofaf107-B88","first-page":"316","article-title":"[Disseminated histoplasmosis in AIDS patients. A study of 2 cases and review of the Spanish literature","volume":"16","author":"Benito","year":"1998","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2025052712075293100_ofaf107-B89","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0014-2565(04)71491-5","article-title":"Histoplasmosis diseminada en dos hermanos con sida","volume":"204","author":"Terrancle de Juan","year":"2004","journal-title":"Rev Cl\u00ednica Esp"},{"key":"2025052712075293100_ofaf107-B90","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eimc.2011.09.014","article-title":"Epidemiolog\u00eda actual y diagn\u00f3stico de laboratorio de las micosis end\u00e9micas en Espa\u00f1a","volume":"30","author":"Buitrago","year":"2012","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"key":"2025052712075293100_ofaf107-B91","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archderm.1989.01670170103019","article-title":"Fever and hyperpigmented papules in an intravenous drug abuser","volume":"125","author":"Freeman","year":"1989","journal-title":"Arch Dermatol"},{"issue":"5N","key":"2025052712075293100_ofaf107-B92","first-page":"60N","article-title":"Acute pulmonary histoplasmosis: newly recognized hazard of marijuana plant hunters","volume":"88","author":"Ram\u00edrez","year":"1990","journal-title":"Am J Med"},{"key":"2025052712075293100_ofaf107-B93","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1086\/599328","article-title":"Methamphetamine enhances histoplasmosis by immunosuppression of the host","volume":"200","author":"Martinez","year":"2009","journal-title":"J Infect Dis"},{"key":"2025052712075293100_ofaf107-B94","author":"Sheikh"},{"key":"2025052712075293100_ofaf107-B95","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol Rev"},{"key":"2025052712075293100_ofaf107-B96","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol Ther"},{"key":"2025052712075293100_ofaf107-B97","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/03602532.2013.849268","article-title":"Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review","volume":"46","author":"Stout","year":"2014","journal-title":"Drug Metab Rev"},{"key":"2025052712075293100_ofaf107-B98","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00007691-200204000-00009","article-title":"Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives","volume":"24","author":"Kraemer","year":"2002","journal-title":"Ther Drug Monit"},{"key":"2025052712075293100_ofaf107-B99","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"2025052712075293100_ofaf107-B100","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents","volume":"48","author":"Br\u00fcggemann","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2025052712075293100_ofaf107-B101","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0090-9556(24)15022-2","article-title":"Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions","volume":"27","author":"Vickers","year":"1999","journal-title":"Drug Metab Dispos"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf107\/62111185\/ofaf107.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/4\/ofaf107\/62111185\/ofaf107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/4\/ofaf107\/62111185\/ofaf107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:08:25Z","timestamp":1748362105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf107\/8037793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf107","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,2,24]]},"article-number":"ofaf107"}}